Stockscreener 앱 받기
2.71
4.23%
0.11
시장 영업 전:
2.63
-0.08
-2.95%
Orchestra Biomed Holdings Inc 주식(OBIO)의 최신 뉴스
Can Orchestra BioMed Holdings Inc. hit a new high this monthAsset Safety Selection Using Quantitative Analysis - Newser
Orchestra BioMed Holdings Inc. stock trend outlook and recovery pathFree Pattern Detection for Entry Confirmation - Newser
Can you recover from losses in Orchestra BioMed Holdings Inc.Free Swing Trading Plan With Smart Signals - Newser
Published on: 2025-08-10 23:50:40 - Newser
Long term hold vs stop loss in Orchestra BioMed Holdings Inc.Free Smart Trade Plans With Risk Protection - Newser
Is Orchestra BioMed Holdings Inc. a candidate for recovery playAnnual Market Behavior and Sector Summary - Newser
Advanced analytics toolkit walkthrough for Orchestra BioMed Holdings Inc.Swing Entry Risk Mitigation with Chart Analysis - Newser
Will Orchestra BioMed Holdings Inc. continue its uptrendFree Capital Preserving Trade Plan Templates - Newser
How to integrate Orchestra BioMed Holdings Inc. into portfolio analysis toolsMomentum Stocks with Breakout Potential - Newser
Real time pattern detection on Orchestra BioMed Holdings Inc. stockFree Weekly Top Gainers Forecast Watchlist - Newser
SEC Filings Archive 2025-08-08Historical 10-K, 10-Q, 8-K Forms - Stock Titan
Regression analysis insights on Orchestra BioMed Holdings Inc. performanceHigh Probability Trade Outcome Prediction - Newser
What MACD and RSI say about Orchestra BioMed Holdings Inc.Value Investing Summary and Earnings Outlook - Newser
Orchestra BioMed stock rises on trial update (OBIO:NASDAQ) - Seeking Alpha
Orchestra BioMed Announces Rollout of FDA-Approved BACKBEAT - GlobeNewswire
FDA Approves 24x Patient Expansion for Orchestra BioMed Hypertension Trial | OBIO Stock News - Stock Titan
Should you wait for a breakout in Orchestra BioMed Holdings Inc.Strategy Playbook for Risk Controlled Trades - Newser
Orchestra Biomed Holdings, Inc. shares fall 2.31% after-hours following a strategic transaction and equity offering. - AInvest
Orchestra BioMed: Chardan Capital Keeps Buy Rating, PT Raised to $20. - AInvest
Signal strength of Orchestra BioMed Holdings Inc. stock in tech scannersChart Scanner for Swing Trade Timing - Newser
Major Investment Alert: Perceptive Advisors Boosts Stake in Orchestra BioMed! - TipRanks
Orchestra BioMed Secures $111 Million - citybiz
Perceptive Advisors buys 700k Orchestra BioMed shares at $2.75 per share. - AInvest
Medtronic (MDT) Invests in Orchestra BioMed's Strategic Expansion - GuruFocus
Orchestra BioMed Raises $111.2M for AVIM Therapy Advancement - AInvest
Orchestra BioMed Secures Over $111 Million in Proceeds and - GlobeNewswire
Orchestra BioMed Secures Massive $111M Funding: Medtronic, Ligand Back Late-Stage Clinical Trials - Stock Titan
Orchestra BioMed’s CEO Makes Bold Stock Purchase! - TipRanks
Orchestra BioMed director Hochman buys $55,000 in OBIO stock By Investing.com - Investing.com Canada
Orchestra BioMed director Hochman buys $55,000 in OBIO stock - Investing.com
Orchestra BioMed Director Hochman Buys 20,000 Shares at $2.75 Per Share - AInvest
Orchestra BioMed Holdings Closes $40M Public Offering - TipRanks
How does Orchestra BioMed Holdings Inc. generate profit in a changing economyAchieve rapid portfolio growth with smart picks - Jammu Links News
Why is Orchestra BioMed Holdings Inc. stock attracting strong analyst attentionCapitalize on emerging market opportunities - Jammu Links News
What is the dividend policy of Orchestra BioMed Holdings Inc. stockFree Consultation - Jammu Links News
What are analysts’ price targets for Orchestra BioMed Holdings Inc. in the next 12 monthsDiscover hidden gems in the stock market - Jammu Links News
Should I hold or sell Orchestra BioMed Holdings Inc. stock in 2025Maximize your gains with professional insights - Jammu Links News
What institutional investors are buying Orchestra BioMed Holdings Inc. stockOver 200% growth - Jammu Links News
What makes Orchestra BioMed Holdings Inc. stock price move sharplyUnlock powerful portfolio optimization tools - Jammu Links News
Is Orchestra BioMed Holdings Inc. a good long term investmentRapid market gains - Jammu Links News
Does Orchestra BioMed Holdings Inc. stock perform well during market downturnsRapid growth opportunities - Jammu Links News
How does Orchestra BioMed Holdings Inc. compare to its industry peersMaximize gains with expert analysis - Jammu Links News
What are Orchestra BioMed Holdings Inc. company’s key revenue driversMarket-crushing stock picks - Jammu Links News
What analysts say about Orchestra BioMed Holdings Inc. stockTriple-digit return opportunities - Jammu Links News
Orchestra BioMed announces pricing of $40 million public offering - MSN
Will Orchestra BioMed Holdings Inc. benefit from macro trendsSummary of Reliable Long-Term Trade Models - Newser
How Orchestra BioMed Holdings Inc. stock performs during market volatilityFree Stock Portfolio Allocation Guidance - Newser
Is Orchestra BioMed Holdings Inc. still worth holding after the dipEntry Zone Watchlist With Momentum Focus - Newser
Trendlines Suggest Orchestra BioMed Holdings Inc. May Bottom Out SoonMarket Momentum and Signal Alerts Suggest Reversal - metal.it
Applying Wyckoff theory to Orchestra BioMed Holdings Inc. stockFree Investment Playbook for Growing Markets - Newser
RSI Reset May Fuel Rebound in Orchestra BioMed Holdings Inc.Long Hold Safe Return Strategy Reviewed - metal.it
Latham Advises on Orchestra BioMed’s US$40 Million Public Offering - Latham & Watkins LLP
Orchestra BioMed Prices $40 Million Public Offering - citybiz
Orchestra BioMed Announces Pricing of $40 Million Public Offering - The Manila Times
Orchestra BioMed Holdings prices public offering of 9.4 million shares at $2.75. - AInvest
Orchestra BioMed Secures $40M Funding to Advance Revolutionary Heart Disease Therapies - Stock Titan
New Product Launches: Will They Boost Orchestra BioMed Holdings Inc. Stock in 2025 - Newser
Why Orchestra BioMed Holdings Inc. is moving todayFree Short Term Buy Zone Stock Alerts - Newser
When is Orchestra BioMed Holdings Inc. stock expected to show significant growthFree Stock Insights For Every Investor - Jammu Links News
0.24%
3.39%
자본화:
|
볼륨(24시간):